596 related articles for article (PubMed ID: 11158001)
21. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
22. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
[TBL] [Abstract][Full Text] [Related]
23. Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared.
Bettica P; Bevilacqua M; Vago T; Masino M; Cucinotta E; Norbiato G
J Clin Endocrinol Metab; 1997 Sep; 82(9):3034-9. PubMed ID: 9284739
[TBL] [Abstract][Full Text] [Related]
24. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
25. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
[TBL] [Abstract][Full Text] [Related]
26. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability.
Orwoll ES; Bell NH; Nanes MS; Flessland KA; Pettinger MB; Mallinak NJ; Cain DF
J Clin Endocrinol Metab; 1998 Nov; 83(11):3930-5. PubMed ID: 9814471
[TBL] [Abstract][Full Text] [Related]
27. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures.
Fisher AA; Southcott EK; Srikusalanukul W; Davis MW; Hickman PE; Potter JM; Smith PN
Ann Clin Lab Sci; 2007; 37(3):222-32. PubMed ID: 17709685
[TBL] [Abstract][Full Text] [Related]
28. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
[TBL] [Abstract][Full Text] [Related]
29. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
30. Diurnal variation of bone mineral turnover in elderly men and women.
Greenspan SL; Dresner-Pollak R; Parker RA; London D; Ferguson L
Calcif Tissue Int; 1997 May; 60(5):419-23. PubMed ID: 9115158
[TBL] [Abstract][Full Text] [Related]
31. Resistance to bone resorbing effects of PTH in black women.
Cosman F; Morgan DC; Nieves JW; Shen V; Luckey MM; Dempster DW; Lindsay R; Parisien M
J Bone Miner Res; 1997 Jun; 12(6):958-66. PubMed ID: 9169356
[TBL] [Abstract][Full Text] [Related]
32. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
33. Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event.
Hahn NM; Yiannoutsos CT; Kirkpatrick K; Sharma J; Sweeney CJ
Clin Genitourin Cancer; 2014 Feb; 12(1):33-40.e4. PubMed ID: 24126237
[TBL] [Abstract][Full Text] [Related]
34. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
[TBL] [Abstract][Full Text] [Related]
35. Role of parathyroid hormone in mediating age-related changes in bone resorption in men.
Kennel KA; Riggs BL; Achenbach SJ; Oberg AL; Khosla S
Osteoporos Int; 2003 Aug; 14(8):631-6. PubMed ID: 12851746
[TBL] [Abstract][Full Text] [Related]
36. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
[TBL] [Abstract][Full Text] [Related]
38. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
[TBL] [Abstract][Full Text] [Related]
39. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
40. Calciotropic hormones and bone markers in the elderly.
Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
